Samsara Therapeutics is a leading brand that aims to restore autophagy to boost cell rejuvenation and reverse currently incurable neurodegenerative and rare genetic diseases. Autophagy, the cell's self-eating process for recycling damaged components, declines with age, and impaired autophagy is linked to serious diseases. Samsara Therapeutics is dedicated to enhancing healthspan by utilizing an unbiased data-driven drug discovery engine.

Through their proprietary data and novel biology insights, they have quickly developed first-in-class, disease-modifying programs with exciting therapeutic activity. Samsara Therapeutics offers the revolutionary Lysoseeker™ Platform, a unique approach for discovering new autophagy therapeutics. In addition, they focus on tackling the cause of neurodegenerative diseases such as Alzheimer's and Parkinson's disease, as well as providing hope for rare genetic diseases.

With their pipeline of cutting-edge autophagy-inducing drugs, Samsara Therapeutics is committed to rejuvenating cells, restoring health, and reversing disease